US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

GSK plc ADRhedged

71.78

+1.151.63%

Volume:16

Turnover:1K

Market Cap:717.92K

PE:- -

High:71.78

Open:70.64

Low:71.78

Close:70.64

52wk High:85.03

52wk Low:56.03

Shares:10.00K

Float Shares:10.00K

Volume Ratio:0.05

T/O Rate:0.16%

Dividend:2.07

Dividend Rate:2.89%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

GSK’s ViiV Healthcare to present new data on INSTI-focused portfolio

GSK plc Stock (GSK) Closed Down by 3.17% on Jul 20: Facts Behind the Movement

GSK Updates Key Pediatric Flu Study, Signaling Quiet Upside for Its Antiviral Portfolio

GSK announces EMA accepted submission to update Bexsero label

GSK Cough Drug Failure Disappoints, but Market was Cautious

Dow Jones Top Company Headlines at 7 PM ET: Walmart Further Shuffles Top Executives | SpaceX ...

GSK plc Stock (GSK) Moved Down by 3.06% on Jul 17: Drivers Behind the Movement

GSK’s ALANIS Trial: Fresh Momentum in AL Amyloidosis Could Reshape Investor Views

GSK Explores Heart Health Upside From Its Next-Gen Vaccines

GSK’s New Asthma Injection Study: Early Signals for Long-Term Investors

European Pharma Stocks' Underperformance Shouldn't Last

GSK Oncology Portfolio Seems Underrated

Sector Update: Healthcare

MT Newswires Live

GlaxoSmithKline (GSK) Gets a Buy from Jefferies

GSK Shares Slide After Drugmaker Drops Chronic Cough Treatment

GlaxoSmithKline (GSK) Gets a Sell from J.P. Morgan

GSK Will Likely Need to Book Write-down on Cough Drug Failure

GSK Stops Camlipixant Program in Refractory Chronic Cough After Phase 3 Data

MT Newswires Live

GSK Halts Camlipixant Development in Chronic Cough After Mixed Phase III Results

GSK Advances New Infant Pneumococcal Vaccine Into Early-Stage Testing

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Easy breezy. No more feesies.","description":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","keywords":"Tiger Brokers,U.S. stock trading,Hong Kong stock trading,trading U.S. stocks,stock information,stock prices,U.S. stock quotes,U.S. stock trading,Hong Kong stock trading,IPO trading,buying U.S. stocks,global investment","social":{"ogDescription":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.thetigerbrokers.com/stock/GSKH/news?page=5"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"NZL","license":"TBKIWI","edition":"fundamental","symbol":"GSKH","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"GSKH\",,,,,undefined,":{"symbol":"GSKH","market":"US","secType":"STK","nameCN":"GSK plc ADRhedged","latestPrice":71.7846,"timestamp":1789675200000,"preClose":70.6364,"halted":0,"volume":16,"delay":0,"changeRate":0.01625507528696257,"floatShares":10001,"shares":10001,"eps":0,"marketStatus":"Pre-Mkt","change":1.1482,"latestTime":"09-18 04:54:15 EDT","open":70.6364,"high":71.7846,"low":71.7846,"amount":1130,"amplitude":0,"askPrice":114.13,"askSize":100,"bidPrice":28.86,"bidSize":100,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1789738200000},"marketStatusCode":1,"adr":0,"exchange":"ARCA","adjPreClose":71.7846,"nav":70.29546,"aum":703024.89546,"dividendRate":0.0289,"bidAskSpread":0,"postHourTrading":{"tag":"盘后","latestPrice":70.6364,"preClose":71.7846,"latestTime":"16:10 EDT","volume":6,"amount":430.7076,"timestamp":1789675804131,"change":-1.1482,"changeRate":-0.015995,"amplitude":0},"volumeRatio":0.04670166839959045,"impliedVol":0.2137,"impliedVolPercentile":0.7265},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"GSKH\",,,,,undefined,":{"symbol":"GSKH","floatShares":10001,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.04670166839959045,"shares":10001,"dividePrice":2.0746,"high":71.7846,"amplitude":0,"preClose":70.6364,"low":71.7846,"week52Low":56.03,"pbRate":"--","week52High":85.03,"institutionHeld":0,"latestPrice":71.7846,"eps":0,"divideRate":0.0289,"volume":16,"delay":0,"ttmEps":0,"open":70.6364,"prevYearClose":68.2031,"prevWeekClose":66.9705,"prevMonthClose":69.8569,"prevQuarterClose":73.8574,"fiveDayClose":67.0681,"twentyDayClose":73.0903,"sixtyDayClose":73.662},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/GSKH\",params:#limit:5,,,undefined,":[{"date":"2026-06-16","symbol":"GSKH","amount":0.92785,"announcedDate":"2026-06-15","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-16","defaultRemindTime":1781616600000,"name":"GSK plc ADRhedged","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-23","payableDate":"2026-06-16","currency":"USD","dateTimestamp":1781582400000,"payDate":"2026-06-23"},{"date":"2026-03-16","symbol":"GSKH","amount":0.36332,"announcedDate":"2026-03-13","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-03-16","defaultRemindTime":1773667800000,"name":"GSK plc ADRhedged","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-03-23","payableDate":"2026-03-16","currency":"USD","dateTimestamp":1773633600000,"payDate":"2026-03-23"},{"date":"2025-12-16","symbol":"GSKH","amount":0.78682,"announcedDate":"2025-12-15","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-16","defaultRemindTime":1765895400000,"name":"GSK plc ADRhedged","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-24","payableDate":"2025-12-16","currency":"USD","dateTimestamp":1765861200000,"payDate":"2025-12-24"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"GSKH\",market:\"US\",,,undefined,":[{"executeDate":"2025-12-16","recordDate":"2025-12-16","paymentDate":"2025-12-24","value":0.78682,"currency":"USD"},{"executeDate":"2026-03-16","recordDate":"2026-03-16","paymentDate":"2026-03-23","value":0.36332,"currency":"USD"},{"executeDate":"2026-06-16","recordDate":"2026-06-16","paymentDate":"2026-06-23","value":0.92785,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"GSKH\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"GSKH\",pageSize:20,pageCount:5,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2653021208","title":"GSK’s ViiV Healthcare to present new data on INSTI-focused portfolio","url":"https://stock-news.laohu8.com/highlight/detail?id=2653021208","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653021208?lang=en_us&edition=fundamental","pubTime":"2026-07-21 21:25","pubTimestamp":1784640316,"startTime":"0","endTime":"0","summary":"GSK (GSK) announced that ViiV Healthcare announced new clinical and real-world data highlighting its integrase strand transfer inhibitor, INSTI, -f...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/gsks-viiv-healthcare-to-present-new-data-on-insti-focused-portfolio-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/gsks-viiv-healthcare-to-present-new-data-on-insti-focused-portfolio-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1829250122.USD","GSKH","XLV","GSK","LU0128526141.USD","BK4532","BK4585","GSK.UK","BK4007","HCSG","BK4581","LABU","BK4137","BK4588","LU0029874061.USD","XBI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653761245","title":"GSK plc Stock (GSK) Closed Down by 3.17% on Jul 20: Facts Behind the Movement","url":"https://stock-news.laohu8.com/highlight/detail?id=2653761245","media":"TradingKey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653761245?lang=en_us&edition=fundamental","pubTime":"2026-07-21 04:15","pubTimestamp":1784578519,"startTime":"0","endTime":"0","summary":"• GSK stock faces downward pressure from ongoing Zantac litigation liabilities and regulatory uncertainty.\n• Heightened competition in vaccine markets and rising research costs impact investor sentiment.\n• Technical indicators, including Williams %R, signal potential selling pressure for the stock.","market":"other","thumbnail":"https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg","type":0,"news_type":0,"thumbnails":["https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tradingkey.com/news/market-movers/262042313-market-movers-gsk-20260720","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4532","GSKH","LU1829250122.USD","BK4588","GSK.UK","BK4007","GSK","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653217133","title":"GSK Updates Key Pediatric Flu Study, Signaling Quiet Upside for Its Antiviral Portfolio","url":"https://stock-news.laohu8.com/highlight/detail?id=2653217133","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653217133?lang=en_us&edition=fundamental","pubTime":"2026-07-21 00:30","pubTimestamp":1784565011,"startTime":"0","endTime":"0","summary":"GlaxoSmithKline ($GSK) announced an update on their ongoing clinical study. GlaxoSmithKline has updated a key pediatric study on its IV flu drug za...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/gsk-updates-key-pediatric-flu-study-signaling-quiet-upside-for-its-antiviral-portfolio?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/gsk-updates-key-pediatric-flu-study-signaling-quiet-upside-for-its-antiviral-portfolio?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4532","GSKH","GSK","GSK.UK","BK4585","BK4588","BK4007","LU1829250122.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652297452","title":"GSK announces EMA accepted submission to update Bexsero label","url":"https://stock-news.laohu8.com/highlight/detail?id=2652297452","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652297452?lang=en_us&edition=fundamental","pubTime":"2026-07-20 18:40","pubTimestamp":1784544023,"startTime":"0","endTime":"0","summary":"GSK (GSK) announced the European Medicines Agency, EMA, has accepted a submission to update the label for Bexsero to include a single dose booster ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/gsk-announces-ema-accepted-submission-to-update-bexsero-label-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/gsk-announces-ema-accepted-submission-to-update-bexsero-label-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","BK4588","LU1829250122.USD","GSK","EPV","GSK.UK","GSKH","BK4532","BK4007","BK4081","EMA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652426246","title":"GSK Cough Drug Failure Disappoints, but Market was Cautious","url":"https://stock-news.laohu8.com/highlight/detail?id=2652426246","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652426246?lang=en_us&edition=fundamental","pubTime":"2026-07-20 13:38","pubTimestamp":1784525880,"startTime":"0","endTime":"0","summary":"0538 GMT - News that a GSK experimental drug for chronic cough achieved negative results in late-stage studies is disappointing, but the market was cautious on the product's chances, Citi analysts say in a research note. Some saw in the drug, camlipixant, a potential candidate to help the U.K. drugmaker offset the patent expiration of its dolutegravir HIV medication, the analysts say. Still, Citi saw the drug as a high-risk asset and assigned it a 25% probability of success in its estimates, equivalent to just 1% of expected GSK revenue for 2035, they add. Similarly, consensus was cautious, with estimated 2035 sales of 750 million pounds for camlipixant accounting for 2% of group revenue, according to Citi. GSK shares closed 2% lower on Friday.  Dow Jones NewswiresJuly 20, 2026 01:38 ET Copyright  2026 Dow Jones & Company, Inc.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4532","BK4007","GSKH","BK4585","GSK","GSK.UK","BK4588","LU1829250122.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652233088","title":"Dow Jones Top Company Headlines at 7 PM ET: Walmart Further Shuffles Top Executives | SpaceX ...","url":"https://stock-news.laohu8.com/highlight/detail?id=2652233088","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652233088?lang=en_us&edition=fundamental","pubTime":"2026-07-18 07:00","pubTimestamp":1784329200,"startTime":"0","endTime":"0","summary":"Walmart Further Shuffles Top ExecutivesKieran Shanahan, chief operating officer for Walmart U.S., will leave this week.----SpaceX in Talks to Provide Computing Power for Pentagon's AI PushElon Musk's company would provide billions of dollars' worth of data-center capacity under the arrangement, people familiar with the matter said.----Nvidia, Challenged by Apple, Narrowly Retains Wall Street's CrownThe iPhone maker briefly became the U.S.'s most valuable publicly traded company on Friday.----China's Moonshot AI Releases Model to Challenge Top U.S. SystemsThe company says its model outperforms some cutting-edge U.S. systems, the latest sign that Chinese labs can rival American counterparts.----Taylor Farms Is Recalling Its Mexican-Grown Iceberg Lettuce From U.S.U.S. authorities have linked the lettuce to a parasitic outbreak across more than 30 states.----Travelers Scored an Earnings Beat. Were the Downgrades All Wrong?","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2087625088.SGD","VT","LU1803068979.SGD","TRV","AIFD","LU0823414478.USD","LU2063271972.USD","VZ","LU1244550221.USD","LU0957808578.USD","BK4505","LU2404859741.USD","LU0726765562.USD","IE0000B7K699.USD","LU0444971666.USD","TEK","IE00BZ1G4Q59.USD","SNVD.UK","LU1496350171.SGD","LU0345774391.USD","SOXQ","SG9999014914.USD","LU1206713676.USD","IE000M9KFDE8.USD","USD","LU1003077747.HKD","AAPL","LU1880398554.USD","LU2083900584.USD","LU1934455194.USD","GSK.UK","IE00BMPRXN33.USD","LU1066051811.HKD","LU1670628061.USD","LU0345774631.USD","WISE","LU1868836757.USD","LU2028103732.USD","SOCL","LU1934455863.HKD","LU2286300806.USD","IE00BJLML261.HKD","LU2750360997.AUD","LU0648001328.SGD","CMA","SG9999014559.SGD","LU1852331112.SGD","LU0097036916.USD","LU2602419157.SGD","LU0476273544.USD","BK4587","IE00BDCRKT87.USD","LU1923623000.USD","LU1366333091.USD","LU0823421416.USD","VGT","LU0557290698.USD","IE00BSNM7G36.USD","BK4592","LU1069347547.HKD","BK4548","IE00B19Z9505.USD","LU1935042488.USD","LU1861215975.USD","LU1323610961.USD","BK4598","LU2360032135.SGD","LU1839511570.USD","LU2023250330.USD","LU0672654240.SGD","LU0949170772.SGD","LU1202635105.USD","IE000F7OJYX1.SGD","LU1564329032.USD","ABFL","IE00B3S45H60.SGD","IE00BJJMRY28.SGD","LU1046421795.USD","LU2506952097.USD","BK4007","CNEQ","LU1506573853.SGD","AMZW","BK4077","LU0143551892.USD","LU0323239441.USD","LU0345770993.USD","BK4550","LU0786609619.USD","LU2347655156.SGD","LU2317271919.USD","LU0256863902.USD","IE00B4JS1V06.HKD","LU0345768740.USD","LU0348723411.USD","LU0208291251.USD","LU0868494708.USD","SG9999000418.SGD","LU2764263039.SGD","GB00BDT5M118.USD","LU0203201768.USD","LU0211331839.USD","LU2360107168.USD","NVYY","LU1829250122.USD","LU1564329115.USD","LU2054465674.USD","SG9999001077.SGD","LU2417539215.USD","AAPW","IE0034235295.USD","BK4515","SGXZ99366536.SGD","LU2458330169.SGD","LU2471134796.USD","LU0689472784.USD","LU0029864427.USD","LU2456880835.USD","LU2191332357.HKD","LU0006306889.USD","BK4604","LU0068578508.USD","SG9999002232.USD","SG9999004303.SGD","SG9999018857.SGD","XLP","BK4533","IE000SO60NU8.SGD","LU0061474960.USD","IE00BD6J9T35.USD","NVDS","LU0648000940.SGD","LU1489326972.SGD","BK4579","LU0314104364.USD","KBWB","LU2362541273.HKD","BK4524","LU0203347892.USD","LU2095319765.USD","METU","LU2420271590.USD","LU0823434583.USD","LU1720051017.SGD","IE00BDRTCR15.USD","IYZ","GSK","LU1861559042.SGD","AAPB","LU0225284248.USD","LU0320765646.SGD","AAPD","ANV","FBYY","IE0004091025.USD","IE00BQXX3D17.EUR","IE00B3SWFQ91.USD","HK0000819398.USD","LU0154236417.USD","SGXZ51526630.SGD","LU0719512351.SGD","LU2247934214.USD","LU2275660780.HKD","LU0965509101.SGD","LU0354030438.USD","LU2430703095.HKD","LU1429558221.USD","FAI","LU2168564149.EUR","LU1316542783.SGD","HK0000304797.USD","LU0345769631.USD","LU0158827948.USD","LU1721428933.USD","LU1582987597.SGD","OGIG","LU2047632596.USD","LU0689626769.HKD","IE0009G5SDU7.USD","LU0965509010.AUD","METV","BK4527","LU1551013425.SGD","LU2237443382.USD","LU0823411888.USD","LU2322448957.HKD","BK4122","LU2237957811.SGD","LU0225771236.USD","LU2491050154.USD","LU1366192091.USD","LU1732799900.SGD","LU2023251221.USD","NVD2.UK","LU1621768115.EUR","LU2471134952.CNY","LU1153585028.USD","IE00BWXC8680.SGD","LU2125909247.SGD","LU1951200564.SGD","SG9999015978.USD","IAK","LU0289961442.SGD","LU1280957306.USD","LU0795875169.SGD","IE00BQXX3F31.USD","LU2756315318.SGD","IE0004445015.USD","LU1301847155.USD","LU3102509885.SGD","GB00B4LPDJ14.GBP","LU0345769128.USD","LU0724617625.USD","LU2271345857.HKD","RSPC","UGE","LU2746668974.SGD","SOXY","JGRO","LU2106854487.HKD","LU2265009873.SGD","IE000MB6IJN5.SGD","IE00BFXG0V08.USD","IE00BHPRN162.USD","LU1989772923.USD","LU0316494557.USD","NVIW.SI","BK4503","2NVD.UK","LU1868837136.USD","AMZN","WMT","LU2462591277.SGD","LU1923622291.USD","BK4504","BK4532","USAW.SI","BK4605","LU0823421333.USD","IE0004086264.USD","LU0306806265.USD","LU1861127337.USD","GB00B4QBRK32.GBP","LU2463028550.USD","IE00B3M56506.USD","LU0265550946.USD","IE00B1XK9C88.USD","FITB","IE00B1BXHZ80.USD","SOXX","AMZY","BK4561","LU0345768153.USD","LU0528227936.USD","LU2237443622.USD","LU2471134879.HKD","LU1127390331.HKD","LU2506951958.HKD","LU2092627202.USD","LU0742534661.SGD","SNPE","LU0079474960.USD","LU0950375773.USD","LU1718418525.SGD","LU2462591350.SGD","IE00BJTD4N35.SGD","IE000BZT7R73.USD","IE000YTNTUN2.SGD","LU0871640123.AUD","LU1267930730.SGD","BK4211","LU2065171311.SGD","IAT","IE00BJJMRX11.SGD","LU1244550494.USD","LU2264538146.SGD","SG9999015945.SGD","LU0128525929.USD","LU2250418816.HKD","LU2637965513.SGD","LU1582986359.USD","LU0472753341.HKD","LU1778281490.HKD","LU0320765489.SGD","IE00BBT3K403.USD","LU0820561909.HKD","LU0175139822.USD","LU1732800096.USD","LU1670627923.USD","LU2244417387.USD","LU1989764748.USD","AMZZ","LU0130103400.USD","LU1934455277.USD","DFNL","SG9999002224.SGD","LU0511384066.AUD","IE00BK4W5L77.USD","LU1883839398.USD","LU2458330243.SGD","LU0133085943.USD","LU0444973449.USD","LU0690374961.EUR","LU1585245621.USD","LU2111349929.HKD","ROM","HK0000532082.HKD","LU2552382132.HKD","IE00B5TLWC47.USD","NVD3.UK","HK0000304805.HKD","LU2125909593.SGD","NVII","LU1823568750.SGD","LU1261432733.SGD","LU1232071149.USD","AMZD","LU0312595415.SGD","LU0788109477.HKD","LU2361045086.USD","BK4141","LU2592432038.USD","LU0170899867.USD","BK4614","LU2242649171.HKD","07788","LU0302445910.USD","LU2125909916.SGD","LU2357305700.SGD","SG9999014575.USD","LU1564329461.SGD","LU2065171402.SGD","IE00BQXX3C00.GBP","LU0347712357.USD","LU0784383803.USD","NVDU","XLC","LU1992135472.HKD","CLIX","LU2023250843.SGD","LU1145028129.USD","LU2487616109.SGD","BK4512","HK0000306685.HKD","LU0138981039.USD","LU0823414551.USD","ONLN","LU2294711713.HKD","LU0094547139.USD","IE00B19Z8W00.USD","LU2092937148.SGD","LU2108987350.USD","LU2471134523.USD","IE00BYQQ9H92.USD","IXN","LU0417517546.SGD","BK4573","LU2087621335.USD","LU1564329628.SGD","LU1074936037.SGD","LU2552382058.USD","LU0985320562.USD","LU1242518931.SGD","BK4559","IE00BFSS8Q28.SGD","LU0320765059.SGD","LU0251132253.USD","LU0314106906.USD","LU1435385759.SGD","LU2860962120.EUR","LU1162221912.USD","LU2357125470.USD","AMZU","BK4543","LU1116320737.USD","LU0082616367.USD","LU0053666078.USD","BK4534","LU2403377893.USD","ILDR","AAPX","HK0000914686.HKD","LU0106261372.USD","LU0225283273.USD","LU0494093205.USD","IE00BKDWB100.SGD","SG9999014898.SGD","LU2100268510.USD","LU0943347566.SGD","FCOM","LU0210528500.USD","LU1116320901.HKD","NVDS.UK","RTH","LU1720051108.HKD","LU1951198990.SGD","HK0000914660.USD","BK4549","LU0061474705.USD","LU2211817866.USD","LU0642271901.SGD","LU0784384876.USD","LU1035775433.USD","LU2065170008.USD","LU2756315664.SGD","LU2347655073.USD","LU2473716301.USD","LU0274383776.USD","LU0306807586.USD","LU0321505439.SGD","LU1621768206.USD","SG9999014880.SGD","LU2362540622.SGD","NVD","LU0310800379.SGD","FTXO","LU0980610538.SGD","LU2360106780.USD","TRFK","LU1935043536.SGD","HK0000306701.USD","TTEQ","LU0210533765.USD","LU1623119135.USD","LU0323591593.USD","LU1059921491.USD","LU1791710400.SGD","IE00BK4W5M84.HKD","LU0795875086.SGD","LU0345770308.USD","LU0289739343.SGD","LU0708994859.HKD","LU1551013342.USD","BK4170","LU0215105999.USD","LU1804176565.USD","LU0820561818.USD","IE0005OL40V9.USD","SG9999001424.SGD","LU0912757837.SGD","LU2236285917.USD","IE0034235303.USD","LU1621767810.EUR","IE0009356076.USD","LU2954938101.SGD","BK4501","LU2210149790.SGD","LU0266013472.USD","LU2746668461.USD","LU0109391861.USD","LU2322448791.USD","LU0267386448.USD","LU1267930490.SGD","07388","LU2326559502.SGD","IE00B19Z3581.USD","BK4608","NULC","LU0203345920.USD","LU2272731782.SGD","LU1691799644.USD","LU2506952170.USD","IE00BKVL7J92.USD","MACW.SI","LU0882574139.USD","LU0957791311.USD","LU1674673428.USD","BK4551","LU0107464264.USD","LU1066053197.SGD","NVDX","LU0323240290.USD","LU1400636657.SGD","METW","LU0466842654.USD","LU2452424414.USD","LU0823417737.USD","LU2361044865.SGD","LU2168563687.JPY","XDAT","SHOC","BK4589","BK4535","LU1235294995.USD","FDTX","SMH","BK4107","LU2381873111.SGD","LU0198837287.USD","FBL","BK4220","LU0251142724.SGD","FSTA","LU0109392836.USD","AIPI","LU1992135399.USD","LU2210150020.SGD","LU0070217475.USD","LU2430703251.USD","LU1791710582.SGD","LU1642822529.SGD","LU1697837992.HKD","IE000W1ABFV2.USD","LU0069063385.USD","BK4571","LU2506951875.HKD","LU0256863811.USD","LU2433249047.HKD","LU2462157665.USD","APLY","IE00B19Z3B42.SGD","HK0000320264.USD","LU1084165304.USD","LU1582987324.SGD","IE0001KFT4U8.USD","LU1069344957.HKD","NVDG","LU0070302665.USD","LU0080751232.USD","LU2896262040.SGD","3NVD.UK","LU2237957902.USD","LU0823434740.USD","GSKH","LU0456855351.SGD","LU2097344431.USD","LFGY","ARTY","LU0985481810.HKD","CHAT","LU0979878070.USD","LU0738911758.USD","LU0965508806.USD","LU0390134368.USD","IE00BMPRXQ63.HKD","LU1035773651.USD","IETC","LU2242650005.HKD","LU2097829019.USD","LU2213496289.HKD","AMZP","LU2430703178.SGD","LU1989771016.USD","LU2999663052.SGD","BK4207","IE0003U64NQ7.SGD","LU2931357623.SGD","LU1914381329.SGD","BK4566","BK4155","BK4581","LU2089985449.USD","BK4574","LU0149725797.USD","LU1206712785.SGD","BK4529","LU1064131342.USD","LU1670711123.USD","TYLG","LU0157215616.USD","LU0238689110.USD","LU2168564065.EUR","LU2168564495.EUR","LU1201861249.SGD","LU2461242641.AUD","LU2764263203.CNY","LU0174119429.USD","LU1645745479.HKD","BK4612","LU2125909759.SGD","LU0011850046.USD","LU1821325948.USD","LTL","LU1400636491.USD","LU0878866978.SGD","LU0056508442.USD","LU2249611893.SGD","LU2237443978.SGD","ESUM","LU2384288077.EUR","IE00B7KXQ091.USD","SG9999017495.SGD","BK4597","LU1066051225.USD","LU0661504455.SGD","LU1633808545.USD","BK4585","LU0210536198.USD","LU0265550359.USD","LU2505996509.AUD","LU1548497426.USD","SPTE","METD","LU2764262908.HKD","SG9999018865.SGD","LU2089283258.USD","NVDA","TFC","LU0081259029.USD","LU0124676726.USD","BK4575","LU2077746001.SGD","LU1814569148.SGD","IE00BJTD4V19.USD","LU0072461881.USD","LU2237443549.SGD","SGXZ23171101.USD","LU0861579265.USD","SG9999015358.SGD","AAPY","LU1988902786.USD","LU2272731865.HKD","LU1861220033.SGD","LU2543165471.USD","LU0353189680.USD","NVDL","LU1119994496.HKD","LU0098860793.USD","LU0949170426.SGD","LU1815333072.USD","LU0130102774.USD","LU1674673691.USD","LU0203202063.USD","LU0127658192.USD","LU0640476718.USD","LU1582986433.USD","SG9999015952.SGD","HK0000320223.HKD","IE00B775H168.HKD","IE00B7SZLL34.SGD","LU0784385840.USD","LU0553294199.USD","IE000ITXATA3.USD","LU0310799852.SGD","IE000Q6AESB8.SGD","LU1868836591.USD","IE0034235188.USD","IE00BMPRXR70.SGD","LU1861558580.USD","LU0545039389.USD","LU1989764664.SGD","WMTI","LU0342679015.USD","LU1621767737.EUR","LU0942090050.USD","BK4596","AZYY","CLSE","LU1400636574.HKD","NVDB","LU0308772762.SGD","LU0683600562.USD","IE00BLSP4452.SGD","IE00BZ199S13.USD","LU0985489474.SGD","LU0964807845.USD","LU1917777945.USD","LU1923622614.USD","LU1670756490.USD","LU2211815571.USD","BK4507","LU0889565833.HKD","LU2720916845.USD","LU0868494617.USD","LU0354030511.USD","LU1880398471.USD","LU0965509283.SGD","LU2133065610.SGD","EFIV","LU0072462426.USD","SMHX","IE00BYXW3230.USD","LU0787776722.HKD","LU0162691827.USD","IE00BFSS7M15.SGD","LU2394011477.USD","BK4588","LU0096364046.USD","LU0552385451.USD","LU1037948897.HKD","LU1291159041.SGD","LU0096362180.USD","LU0289941410.SGD","FTEC","LU0784385170.HKD","XLK","LU2413666426.HKD","VOX","LU2413666699.HKD","IE0002270589.USD","AGOX","KBWP","SG9999015341.SGD","SGXZ81514606.USD","IE00BLSP4239.USD","LU1571399168.USD","LU0211327993.USD","LU2125154935.USD","LU1430594728.SGD","IE0004445239.USD","LU0048584097.USD","LU1983260115.SGD","NVDY","LU1037948541.HKD","LU2237443465.HKD","IE000WAW04H5.SGD","LU2362541513.USD","LU2361044949.HKD","BK4553","LU2491050071.SGD","BK4554","NVDO","LU1815336760.USD","LU2290526834.HKD","DIPS","LU1496350502.SGD","NVDW","BK4576","LU1935042215.USD","LU0708995401.HKD","LU2404859667.USD","FBY","LU0251131958.USD","BK4115","LU0234570918.USD","META","LU2023250504.SGD","LU1670711040.USD","NVDQ","LU2491049909.HKD","LU1670710588.SGD","LU1989772840.SGD","BK4538","IE000KEQY171.SGD","SG9999014906.USD","LU2148611432.USD","LU2506951792.HKD","WANT","LU0077335932.USD","LU1712237335.SGD","LU0158827781.USD","LU1699723380.USD","LU0276348264.USD","LU1629891620.HKD","LU2272731600.USD","BK4567","IE00B19Z8X17.USD","SGXZ31699556.SGD","LU2097344357.USD","LU1242518857.USD","LU1935042991.SGD","IE00B4YYXB79.USD","NVDD","LU0057025933.USD","SG9999015986.USD","LU0433182093.SGD","IE00BN8TJ469.HKD","LU0690374615.EUR","SG9999014542.SGD","SG9999014567.USD","LU0823417653.USD","LU0211328371.USD","LU2125154778.USD","LU1201861165.SGD","LU1974910355.USD","LU0820562030.AUD","LU2089284900.SGD","LU2505996681.GBP","LU2168564222.USD","IE00B5949003.HKD","IE00BKPKM429.USD","LU1267930573.SGD","LU1868837300.USD","LU2552382215.SGD","LU2237438978.USD","LU0187121727.USD","LU0321505868.SGD","LU0353189763.USD","LU2237443895.HKD","IE00BFXG1179.USD","LU2750360641.GBP","IE00B775SV38.USD","LU1935043023.USD","LU0048573561.USD","LU2065169927.USD","AAPU","LU0234572021.USD","IE00BN29S564.USD","LU1244550577.SGD","LU1868836914.USD","USXF","LU0061475181.USD","LU0289960550.SGD","LU1670710661.SGD","LU1066051498.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652128784","title":"GSK plc Stock (GSK) Moved Down by 3.06% on Jul 17: Drivers Behind the Movement","url":"https://stock-news.laohu8.com/highlight/detail?id=2652128784","media":"TradingKey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652128784?lang=en_us&edition=fundamental","pubTime":"2026-07-18 02:15","pubTimestamp":1784312115,"startTime":"0","endTime":"0","summary":"• GSK shares face volatility due to ongoing Zantac litigation and potential settlement liabilities.\n• Industry pricing pressures and shifting institutional investment contribute to downward stock performance.\n• Uncertain clinical pipeline results and currency fluctuations impact the company's valuation and earnings.","market":"sg","thumbnail":"https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg","type":0,"news_type":0,"thumbnails":["https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tradingkey.com/news/market-movers/262038442-market-movers-gsk-20260717","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","GSK","GSK.UK","LU1829250122.USD","BK4007","GSKH","BK4532","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652840282","title":"GSK’s ALANIS Trial: Fresh Momentum in AL Amyloidosis Could Reshape Investor Views","url":"https://stock-news.laohu8.com/highlight/detail?id=2652840282","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652840282?lang=en_us&edition=fundamental","pubTime":"2026-07-18 00:32","pubTimestamp":1784305947,"startTime":"0","endTime":"0","summary":"GlaxoSmithKline ($GSK) announced an update on their ongoing clinical study. The ALANIS study from GlaxoSmithKline (GSK) is a Phase 2 trial testing ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/gsks-alanis-trial-fresh-momentum-in-al-amyloidosis-could-reshape-investor-views?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/gsks-alanis-trial-fresh-momentum-in-al-amyloidosis-could-reshape-investor-views?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4104","IE00B19Z6F94.USD","GSK","BK4532","GSK.UK","GSKH","BBC","BK4585","PSIL","BK4007","AL","BK4588","IE0034390439.USD","LU1169590202.USD","LU1829250122.USD","BK4572","LU1169589451.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652073284","title":"GSK Explores Heart Health Upside From Its Next-Gen Vaccines","url":"https://stock-news.laohu8.com/highlight/detail?id=2652073284","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652073284?lang=en_us&edition=fundamental","pubTime":"2026-07-18 00:31","pubTimestamp":1784305901,"startTime":"0","endTime":"0","summary":"GlaxoSmithKline ($GSK) announced an update on their ongoing clinical study. GSK tests vaccines for heart risk in adults 50+. The study, “A Randomiz...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/gsk-explores-heart-health-upside-from-its-next-gen-vaccines?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/gsk-explores-heart-health-upside-from-its-next-gen-vaccines?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","BK4007","BK4588","BK4532","GSK.UK","GSK","LU1829250122.USD","GSKH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652284045","title":"GSK’s New Asthma Injection Study: Early Signals for Long-Term Investors","url":"https://stock-news.laohu8.com/highlight/detail?id=2652284045","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652284045?lang=en_us&edition=fundamental","pubTime":"2026-07-18 00:31","pubTimestamp":1784305861,"startTime":"0","endTime":"0","summary":"GlaxoSmithKline ($GSK) announced an update on their ongoing clinical study. GSK Bioavailability Trial Offers Fresh Insight for Asthma Investors. Th...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/gsks-new-asthma-injection-study-early-signals-for-long-term-investors?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/gsks-new-asthma-injection-study-early-signals-for-long-term-investors?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","GSKH","GSK.UK","GSK","LU1829250122.USD","BK4585","ISBC","BK4532","BK4211","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652286740","title":"European Pharma Stocks' Underperformance Shouldn't Last","url":"https://stock-news.laohu8.com/highlight/detail?id=2652286740","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652286740?lang=en_us&edition=fundamental","pubTime":"2026-07-17 22:13","pubTimestamp":1784297580,"startTime":"0","endTime":"0","summary":"1413 GMT - European pharma stocks are lagging behind the broader market, but the sector should benefit as investors start to look for trades beyond big tech, Intron Health's Naresh Chouhan and Dominic Rose say in a research note. This year's underperformance came after pricing deals with the Trump administration at the end of last year boosted the sector, Intron says. \"We do not believe investors have fallen out of love with pharma, it is just that many believe the sector is up with events for now,\" the analysts say. Upcoming strategy updates from companies like GSK, Novo Nordisk and Roche, and potential gains from AI should help pharma stocks, they add. Intron says it favors UCB, AstraZeneca, Roche and Novartis in the near term. The Stoxx Europe 600 Health Care index rises 0.3%.  Dow Jones NewswiresJuly 17, 2026 10:13 ET Copyright  2026 Dow Jones & Company, Inc.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BKVL7J92.USD","LU0320765489.SGD","IE00BJJMRZ35.SGD","IE0009355771.USD","LU2237443465.HKD","LU0208291251.USD","LU0128525929.USD","BK4585","BK4568","CANC","LU0109394709.USD","HRTS","LU0289739699.SGD","NVS","LU2468319806.SGD","LU0708994859.HKD","MEDX","BK4532","LU0432979614.USD","LU2462157665.USD","RHHBY","PPH","AZN","GSK.UK","IE00B4R5TH58.HKD","LU1267930573.SGD","LU0154236417.USD","THNR","BK4578","BK4007","LU0029864427.USD","03165","LU1093756325.SGD","IE00BJT1NW94.SGD","LU0058720904.USD","LU2236285917.USD","NVOX","BK4599","LU1093756168.USD","OZEM","AZNH","IE00BFTCPJ56.SGD","LU2237443382.USD","GSKH","LU2456880835.USD","LU2089984988.USD","LU1829250122.USD","EPV","LU0310800379.SGD","LU0320765992.SGD","LU2237443622.USD","LU2237443549.SGD","LU2237443895.HKD","LU0889565916.HKD","LU2417539215.USD","NVOH","LU2237443978.SGD","IE00BZ1G4Q59.USD","IE00B3T34201.USD","LU0070302665.USD","BK4588","NVO","LU0211331839.USD","GSK","IE0002141913.USD","IE00B2B36J28.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652666286","title":"GSK Oncology Portfolio Seems Underrated","url":"https://stock-news.laohu8.com/highlight/detail?id=2652666286","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652666286?lang=en_us&edition=fundamental","pubTime":"2026-07-17 21:51","pubTimestamp":1784296260,"startTime":"0","endTime":"0","summary":"1351 GMT - GSK's oncology business has stronger assets than it is credited for and they could make a difference next decade, analysts at Jefferies say in a research note. The U.K. drugmaker has made a number of deals that add revenue potential without putting too much pressure on profitability and it still has room for more over the next few years, according to Jefferies. \"The acquisitions of IDRx as well as Nuvalent have added assets to the oncology portfolio that have one thing in common--long duration of therapy plus an ability to move up the treatment cascade,\" the analysts say. \"They are highly profitable assets that should start to contribute to the top-line as the HIV business starts to slow down.\" Shares fall 1.7%.  Dow Jones NewswiresJuly 17, 2026 09:51 ET Copyright  2026 Dow Jones & Company, Inc.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GSK.UK","BK4585","BK4007","LU1829250122.USD","BK4588","BK4532","GSK","GSKH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652858612","title":"Sector Update: Healthcare","url":"https://stock-news.laohu8.com/highlight/detail?id=2652858612","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652858612?lang=en_us&edition=fundamental","pubTime":"2026-07-17 20:59","pubTimestamp":1784293167,"startTime":"0","endTime":"0","summary":"Healthcare stocks were mixed premarket Friday, with the State Street Health Care Select Sector SPDR ETF  up 0.3% and the iShares Biotechnology ETF  0.6% lower.GSK  shares were down more than 2% after the company said it will discontinue development of camlipixant for refractory chronic cough after the drug produced mixed results in the phase 3 CALM-1 and CALM-2 trials.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4588","LABU","XBI","LU1829250122.USD","GSK.UK","BK4581","BK4532","GSKH","LU0128526141.USD","HCSG","BK4137","GSK","BK4585","IBB","BK4007","LU0029874061.USD","XLV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652855285","title":"GlaxoSmithKline (GSK) Gets a Buy from Jefferies","url":"https://stock-news.laohu8.com/highlight/detail?id=2652855285","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652855285?lang=en_us&edition=fundamental","pubTime":"2026-07-17 20:55","pubTimestamp":1784292936,"startTime":"0","endTime":"0","summary":"Jefferies analyst Michael Leuchten maintained a Buy rating on GlaxoSmithKline today and set a price target of £25.00. According to TipRanks, Leucht...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/glaxosmithkline-gsk-gets-a-buy-from-jefferies-blurbs-news-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/glaxosmithkline-gsk-gets-a-buy-from-jefferies-blurbs-news-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1829250122.USD","BK4585","GSK","GSK.UK","GSKH","BK4532","BK4588","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652834082","title":"GSK Shares Slide After Drugmaker Drops Chronic Cough Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=2652834082","media":"Dow Jones","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652834082?lang=en_us&edition=fundamental","pubTime":"2026-07-17 20:52","pubTimestamp":1784292720,"startTime":"0","endTime":"0","summary":"GSK shares fell after the U.K. drugmaker said it would stop working on an experimental treatment for chronic cough that showed limited efficacy in late-stage clinical studies.Shares in GSK were down 3","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"GSK Shares Slide After Drugmaker Drops Chronic Cough Treatment","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","BK4585","GSK.UK","GSK","BK4588","GSKH","BK4532","LU1829250122.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652285851","title":"GlaxoSmithKline (GSK) Gets a Sell from J.P. Morgan","url":"https://stock-news.laohu8.com/highlight/detail?id=2652285851","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652285851?lang=en_us&edition=fundamental","pubTime":"2026-07-17 20:45","pubTimestamp":1784292326,"startTime":"0","endTime":"0","summary":"In a report released today, Zain Ebrahim from J.P. Morgan maintained a Sell rating on GlaxoSmithKline, with a price target of £17.00. According to ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/glaxosmithkline-gsk-gets-a-sell-from-j-p-morgan-blurbs-news-3?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/glaxosmithkline-gsk-gets-a-sell-from-j-p-morgan-blurbs-news-3?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0557290698.USD","LU2023251221.USD","LU2028103732.USD","LU2133065610.SGD","LU2264538146.SGD","BK4585","LU1064131342.USD","BK4504","GSK","LU0528227936.USD","LU1988902786.USD","LU0795875086.SGD","BK4127","LU0882574139.USD","LU1244550494.USD","LU0314104364.USD","LU0234570918.USD","GSK.UK","LU1548497426.USD","LU1720051108.HKD","LU0106831901.USD","BK4516","GSKH","LU2487616109.SGD","IE00BKVL7J92.USD","LU1791710582.SGD","LU1074936037.SGD","LU0320765646.SGD","LU1668664300.SGD","BK4588","IE00BZ1G4Q59.USD","LU1829250122.USD","BK4532","LU0971096721.USD","LU1244550221.USD","LU2089284900.SGD","LU0158827781.USD","LU1732800096.USD","LU1162221912.USD","LU2357305700.SGD","KBWB","IAI","LU1791710400.SGD","LU0158827948.USD","LU0795875169.SGD","LU1989772923.USD","BK4534","LU1363072403.SGD","LU2089283258.USD","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652288658","title":"GSK Will Likely Need to Book Write-down on Cough Drug Failure","url":"https://stock-news.laohu8.com/highlight/detail?id=2652288658","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652288658?lang=en_us&edition=fundamental","pubTime":"2026-07-17 19:57","pubTimestamp":1784289420,"startTime":"0","endTime":"0","summary":"1156 GMT - GSK will likely need to take a write-down on an experimental drug for chronic cough after it stopped clinical development, J.P. Morgan analysts say in a research note. The U.K. drugmaker said it decided to terminate development of the drug for chronic cough after it delivered mixed results in a late-stage study and missed primary and secondary objectives in another trial. JPM estimated peak sales for the drug at 1.4 billion pounds, with 2031 sales forecast at 300 million pounds. GSK's recent acquisition of Nuvalent is likely to offset some of the hit from the loss of camlipixant, but shares are still expected to be under pressure, the analysts say. Shares fall 3.7%.  Dow Jones NewswiresJuly 17, 2026 07:57 ET Copyright  2026 Dow Jones & Company, Inc.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","LU1829250122.USD","GSKH","BK4007","GSK.UK","GSK","BK4585","BK4532"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652402537","title":"GSK Stops Camlipixant Program in Refractory Chronic Cough After Phase 3 Data","url":"https://stock-news.laohu8.com/highlight/detail?id=2652402537","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652402537?lang=en_us&edition=fundamental","pubTime":"2026-07-17 18:22","pubTimestamp":1784283728,"startTime":"0","endTime":"0","summary":"GSK  will discontinue development of camlipixant for refractory chronic cough after the drug produced mixed results in the phase 3 CALM-1 and CALM-2 trials, the company said Friday.In the phase 3 program, camlipixant 50 mg twice daily significantly reduced 24-hour cough frequency versus placebo in CALM-1 but failed to reach statistical significance in CALM-2, while the 25 mg dose failed to meet the primary endpoint in both trials.GSK said limited efficacy prompted its decision to discontinue camlipixant's development in refractory chronic cough, while the phase 2b BALANCE trial in irritable bowel syndrome will continue.GSK shares were down over 3% in premarket activity Friday.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["GSKH","BK4532","BK4585","GSK.UK","LU1829250122.USD","GSK","BK4007","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652406846","title":"GSK Halts Camlipixant Development in Chronic Cough After Mixed Phase III Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2652406846","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652406846?lang=en_us&edition=fundamental","pubTime":"2026-07-17 16:32","pubTimestamp":1784277143,"startTime":"0","endTime":"0","summary":"The latest update is out from GlaxoSmithKline ( ($GB:GSK) ). GSK has reported mixed phase III results for its P2X3 receptor antagonist camlipixant ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/gsk-halts-camlipixant-development-in-chronic-cough-after-mixed-phase-iii-results?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/gsk-halts-camlipixant-development-in-chronic-cough-after-mixed-phase-iii-results?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4134","GSK","GSK.UK","LU1829250122.USD","BK4588","BK4532","BK4585","BK4007","GSKH","III"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652042578","title":"GSK Advances New Infant Pneumococcal Vaccine Into Early-Stage Testing","url":"https://stock-news.laohu8.com/highlight/detail?id=2652042578","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652042578?lang=en_us&edition=fundamental","pubTime":"2026-07-17 00:31","pubTimestamp":1784219518,"startTime":"0","endTime":"0","summary":"GlaxoSmithKline ($GSK) announced an update on their ongoing clinical study. GlaxoSmithKline is launching a Phase 1 trial to test an infant pneumoco...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/gsk-advances-new-infant-pneumococcal-vaccine-into-early-stage-testing?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/gsk-advances-new-infant-pneumococcal-vaccine-into-early-stage-testing?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["GSK.UK","BBC","BK4007","GSKH","BK4532","LU1829250122.USD","BK4585","GSK","BK4588"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":5,"totalSize":200,"code":"91000000","status":"200"}]}}